4 Biotechs Ready to Kill the Market in 2018


The year 2017 has been quite a impressive one for the biotech sector as evident from the 19.4% gain registered so far by the NASDAQ Biotechnology Index (^. This is surely welcome news for investors since the industry suffered a decline of 19.2% last year.



from Biotech News